...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Mutagenesis of Ly49B reveals key structural elements required for promiscuous binding to MHC class I molecules and new insights into the molecular evolution of Ly49s
【24h】

Mutagenesis of Ly49B reveals key structural elements required for promiscuous binding to MHC class I molecules and new insights into the molecular evolution of Ly49s

机译:Ly49B的诱变揭示了与MHC I类分子混杂结合所需的关键结构元件,以及对Ly49s分子进化的新见解

获取原文
获取原文并翻译 | 示例

摘要

Ly49B is a potentially important immunoregulator expressed on mouse myeloid cells, and it is thus an unusual member of the wider Ly49 family whose members are ordinarily found on NK cells. Ly49B displays substantial sequence divergence from other Ly49s and in particular shares virtually no amino acid sequence identity with the residues that have been reported to bind to MHC class I (cI) ligands in other Ly49s. Despite this, we show in this study that the BALB/c, but not the C57, isoform of Ly49B displays promiscuous cI binding. Binding was not significantly affected by inactivation of any of the four predicted N-linked glycosylation sites of Ly49B, nor was it affected by removal of the unique 20-aa C-terminal extension found in Ly49B. However, transfer of these C-terminal 20 aa to Ly49A inhibited cI binding, as did the addition of a hemagglutinin tag to the C terminus of Ly49B, demonstrating unexpectedly that the C-terminal region of Ly49s can play a significant role in ligand binding. Systematic exchange of BALB/c and C57 residues revealed that Trp166, Asn167, and Cys251 are of major importance for cI binding in Ly49B. These residues are highly conserved in the Ly49 family. Remarkably, however, Ly49BBALB variants that have C57 residues at positions 166 or 167, and are unable to bind cI multimers, regain substantial cI binding when amino acid changes are made at distal positions, providing an explanation of how highly divergent Ly49s that retain the ability to bind cI molecules might have evolved.
机译:Ly49B是在小鼠骨髓细胞上表达的潜在重要的免疫调节剂,因此它是更广泛的Ly49家族的不寻常成员,其成员通常在NK细胞上发现。 Ly49B与其他Ly49s表现出显着的序列差异,特别是与据报道与其他Ly49s中的MHC I类(cI)配体结合的残基几乎没有氨基酸序列同一性。尽管如此,我们在这项研究中显示,Ly49B的BALB / c,而不是C57,表现出混杂的cI结合。结合不会因Ly49B的四个预测的N-联糖基化位点的失活而受到显着影响,也不受去除Ly49B中独特的20-aa C端延伸的影响。但是,将这些C末端20个氨基酸转移到Ly49A上会抑制cI结合,就像在Ly49B的C末端添加血凝素标签一样,出乎意料地证明了Ly49s的C末端区域可以在配体结合中发挥重要作用。 BALB / c和C57残基的系统交换表明,Trp166,Asn167和Cys251对于Ly49B中的cI结合至关重要。这些残基在Ly49家族中是高度保守的。然而,值得注意的是,Ly49BBALB变异体在166或167位具有C57残基,并且无法结合cI多聚体,当在远端位置进行氨基酸改变时又重新获得了实质性的cI结合,从而说明了保持能力的Ly49s高度差异性的原因。结合cI分子可能已经进化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号